Jill Beierle

Placeholder Person Graphic
Amgen
Manager in Regulatory Affairs-CMC
Jill Beierle, MS, is a Manager in Regulatory Affairs-CMC at Amgen, Inc., and on the advocacy and external engagement team. Jill has a wide range of experience ranging from early discovery proteomics, formulation, and quality including leading regulatory filings in early and late stage programs. Areas of high interest include collaboration in crossfunctional areas to identify new technologies to acquire information concerning scientific developments that can impact product development in design and data analysis for improved regulatory outcomes. Jill is active in organizations such as IQ. She holds a master's degree in regulatory science from the University of Southern California School of Pharmacy. Jill joined ISPE in 2021.

Related Articles

Regulatory Landscape for Raw Materials: CMC Considerations
Features
Regulatory Landscape for Raw Materials: CMC Considerations

A reliable supply of raw materials is critical to maintain a robust supply chain to serve patients globally. With shortages, regulatory complexity is compounded due to differences in submission and data requirements from various regulatory agencies. Therefore, there is an increasing need to implement a harmonized regulatory infrastructure that is both flexible and predictable to provide more...

Figure 3: Industry develops a single global control strategy.
Features
Toward a Single Global Control Strategy: Industry Study

During the past decade, industry has experienced a proliferation of regulatory divergence regarding the interpretation and implementation of International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines (and control strategies) across geographic regions. This article shares data that highlight instances where well-established ICH...